Physical stretching of the intestine independently suppresses appetite and improves glucose control in mice, but obesity impairs this response — and weight loss restores it.
Stretch-induced satiety works without GLP-1Intestinal stretching suppressed food intake and improved glucose tolerance through a mechanism completely independent of GLP-1 signaling and vagal mechanosensation
What the researchers found
Intestinal stretch — independent of nutrients and gut hormones — suppresses food intake and improves glucose tolerance in mice. Using mannitol (a nonnutritive substance) to selectively stretch the intestine, researchers showed this mechanical signal acutely reduces eating and improves oral glucose tolerance without relying on GLP-1 signaling or vagal mechanosensation. Critically, diet-induced obesity impaired this stretch response, reducing both feeding suppression and neuronal activation in the nucleus of the solitary tract (NTS). Both dietary weight loss and vertical sleeve gastrectomy (VSG) restored the impaired stretch-induced feeding suppression and enhanced NTS neuronal activation. VSG specifically heightened NTS neuronal activation in response to oral (but not injected) glucose.
Why it matters
This study reveals a previously underappreciated mechanism for appetite control — pure physical stretching of the intestine, separate from nutrient sensing or gut hormone release. The finding that obesity breaks this mechanism (and that weight loss restores it) adds a new dimension to understanding why obese individuals struggle with satiety. It also provides insight into why bariatric surgery works: VSG may partially restore the gut's mechanical signaling to the brain.
How the study worked
Mouse study using mannitol to induce intestinal stretch without providing nutrients. Food intake, oral glucose tolerance, and brain neuronal activation (NTS) were measured in lean mice, diet-induced obese mice, and mice after weight loss (dietary intervention or vertical sleeve gastrectomy). Chemogenetic approaches inhibited GLP-1R and OxtR-expressing vagal afferents. Genetic and pharmacological strategies ablated GLP-1 signaling to test whether stretch effects were GLP-1-independent.
Who was studied
C57BL/6 mice: lean, diet-induced obese, and post-weight-loss (dietary and VSG)
What this study cannot tell us
Animal study in mice, which may not directly translate to human physiology. Mannitol-induced stretch is an artificial stimulus that may not perfectly replicate normal post-meal intestinal distension. The study focused on acute effects; chronic or repeated stretch responses were not assessed. Specific neuronal pathways mediating GLP-1-independent effects remain to be fully characterized.
How to read the evidence
Preclinical mouse study using sophisticated techniques (chemogenetics, genetic knockouts, pharmacological ablation). Provides strong mechanistic evidence but has not been tested in humans.
When this study was published
Published in 2025 in Molecular Metabolism. This is cutting-edge research that challenges the current GLP-1-centric view of gut-based satiety regulation.
The bigger picture
Most obesity research focuses on gut hormones like GLP-1, GIP, and PYY. This study highlights a parallel system — mechanical signaling — that operates independently. The finding that GLP-1 drugs' popularity may overshadow other important satiety mechanisms is significant. It also helps explain why bariatric surgery produces benefits beyond what hormonal changes alone can account for: VSG may physically restructure how the gut communicates with the brain. Understanding both chemical and mechanical satiety pathways could lead to more comprehensive obesity treatments.
Questions still open
- Could therapies that enhance intestinal mechanosensation complement GLP-1 drugs for obesity treatment?
- Does the impaired stretch response in obesity also occur in humans, and can it be measured clinically?
- What specific neural pathway mediates GLP-1-independent intestinal stretch signaling to the brain?
Common questions
If this doesn't involve GLP-1, why is it relevant to GLP-1 drug research?
Does this explain why people feel less full when they're obese?
Read the original research
Weight loss reverses obesity-associated impairments in acute gastrointestinal stretch-induced suppression of food intake and glucose homeostasis.
Molecular metabolism, 102, 102260
Citation
Bethea, Maigen; Cook, Tyler; Mommandi, Marwa; McClennan, Andrew; Martin, Allison; Hendrix, Jasmine J; Hutch, Chelsea R; Lewis, Alfor; Seeley, Randy J; Fenselau, Henning; da Silva Teixeria, Silvania; Sandoval, Darleen A. (2025). Weight loss reverses obesity-associated impairments in acute gastrointestinal stretch-induced suppression of food intake and glucose homeostasis.. Molecular metabolism, 102, 102260. https://doi.org/10.1016/j.molmet.2025.102260